3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
32
Breast Neoplasms
25
Fallopian Tube Neoplasms
21
Multiple Myeloma
18
Carcinoma, Ovarian Epithelial
14
Lymphoma
8
Triple Negative Breast Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hodgkin Disease
3
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Patient Participation
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Interventions
Temozolomide
53
Bevacizumab
33
Radiotherapy
27
Radiation
12
Erlotinib Hydrochloride
12
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
8
Irinotecan
6
Vorinostat
5
Sorafenib
5
Sirolimus
5
temsirolimus
4
Magnetic Resonance Spectroscopy
4
Immunoglobulin G
4
Disulfides
4
Carmustine
4
veliparib
3
plerixafor
3
carmustine, poliferprosan 20 drug combination
3
Radiosurgery
3
Everolimus
3
Dasatinib
3
Bortezomib
3
vandetanib
2
tandutinib
2
sargramostim
2
poly ICLC
2
pembrolizumab
2
pazopanib
2
ferric pyrophosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gliosarcoma
×
liposomal doxorubicin
×
Clear all
No trials found.